CJC/IPA 10MG
$95.00
The CJC-1295 NO DAC 5MG + IPAMORELIN 5MG blend is a sophisticated research compound designed to investigate the synergistic interaction between a growth hormone-releasing hormone (GHRH) analog and a growth hormone secretagogue (GHS). This precision-formulated blend is tailored for laboratory research into the modulation of endocrine signaling pathways and the study of growth hormone dynamics in controlled environments. By combining CJC-1295 (without DAC) and Ipamorelin in a single, high-purity lyophilized vial, this product provides researchers with a consistent and reliable reference material for analyzing the pulsatile release of growth hormone. Researchers studying this compound can examine how the GHRH-mimetic action of CJC-1295 NO DAC works in tandem with the selective GHS properties of Ipamorelin. This synergistic approach is frequently utilized in experimental models to investigate the pathways regulating hormonal output, cellular repair signaling, and metabolic homeostasis. The inclusion of the non-DAC version of CJC-1295 allows for the study of shorter-acting, more frequent pulse-like release profiles, which can be contrasted with longer-acting alternatives in metabolic research. This formulation is engineered for stability and consistency, ensuring you receive a reliable compound for your scientific inquiries. We prioritize quality control to provide you with the most effective support for your research objectives. Please note: This product is strictly for laboratory research use only and is not intended for human consumption or therapeutic use. COA'S available upon request.
Stored at site: Storage